Susquehanna International Group, LLP Coherus Bio Sciences, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 49,404 shares of CHRS stock, worth $52,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,404
Previous 139,053
64.47%
Holding current value
$52,862
Previous $144,000
52.78%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CHRS
# of Institutions
130Shares Held
67.8MCall Options Held
1.68MPut Options Held
91.8K-
Black Rock Inc. New York, NY11.8MShares$12.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$11.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.28MShares$5.65 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$5.63 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA3.65MShares$3.91 Million0.38% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $83.2M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...